Focusing attention on the molecular mechanisms related to the role of resveratrol in alcoholic fatty liver disease—the activation of SIRT1 (sirtuin 1) and AMPK (AMP-activated kinase)—two critical signalling molecules that regulate the metabolic pathways of liver lipids were highlighted [24,25]. This evidence concerns the gene SIRT1 and alcoholic fatty liver disease.